UVADEX
Google image searchProduct monograph
Active ingredient
methoxsalen, 20 MCG/ML
DIN: 02406233
Dosage form(s): SOLUTION
Route(s) of administration: EXTRACORPOREAL
Description: TO BE ADMINSTERED VIA THE UVAR XTS OR THERAKOS CELLEX PHOTOPHERESIS SYSTEMS
Schedule: Prescription
Company: THERAKOS INC
Date: 09-DEC-2013
ATC:
- D05 — ANTIPSORIATICS (ATC, ATC/DDD, )
- D05B — ANTIPSORIATICS FOR SYSTEMIC USE (ATC, ATC/DDD)
- D05BA — Psoralens for systemic use (ATC, ATC/DDD)
- D05BA02 — METHOXALEN, SYSTEMIC (ATC/DDD)
Reference brand drug: Oxsoralen, Uvadex
